Aspen Pharmacare Total Assets 2017-2023 | APNHY

Aspen Pharmacare total assets from 2017 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Aspen Pharmacare total assets for the quarter ending June 30, 2023 were $7.574B, a 5.02% decline year-over-year.
  • Aspen Pharmacare total assets for 2023 were $7.574B, a 3.35% increase from 2022.
  • Aspen Pharmacare total assets for 2022 were $7.328B, a 2.48% increase from 2021.
  • Aspen Pharmacare total assets for 2021 were $7.151B, a 16.61% decline from 2020.
Aspen Pharmacare Annual Total Assets
(Millions of US $)
2023 $7,574
2022 $7,328
2021 $7,151
2020 $8,576
2019 $8,623
2018 $10,374
2017 $8,548
2016 $7,238
2015 $0
Aspen Pharmacare Quarterly Total Assets
(Millions of US $)
2023-06-30 $7,574
2022-06-30 $7,328
2021-12-31 $7,627
2021-06-30 $7,151
2020-12-31 $7,974
2020-06-30 $8,576
2019-06-30 $8,623
2018-12-31 $9,424
2018-06-30 $10,374
2017-12-31 $9,004
2017-06-30 $8,548
2016-12-31 $7,762
2016-06-30 $7,238
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.038B $2.296B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.855B 5.36
Dr Reddy's Laboratories (RDY) India $12.352B 19.53
BridgeBio Pharma (BBIO) United States $4.278B 0.00
Bausch Health Cos (BHC) Canada $3.150B 2.46
Amphastar Pharmaceuticals (AMPH) United States $1.995B 13.66
Supernus Pharmaceuticals (SUPN) United States $1.604B 0.00
Taysha Gene Therapies (TSHA) United States $0.430B 0.00
Generation Bio (GBIO) United States $0.200B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Personalis (PSNL) United States $0.063B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00